What is Moderna's collaboration receivable?

Moderna (MRNA) reported collaboration receivable of $1.00M in Q1 2026.

How has Moderna's collaboration receivable changed year-over-year?

Moderna's collaboration receivable decreased by 96.2% year-over-year, from $26.00M to $1.00M.

What is the long-term trend for Moderna's collaboration receivable?

Over 3 years (2022 to 2025), Moderna's collaboration receivable has grown at a 5.7% compound annual growth rate (CAGR), from $11.00M to $13.00M.

Other

Collaboration receivable

Moderna Collaboration receivable decreased by 92.3% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 96.2%, from $26.00M to $1.00M. Over 3 years (FY 2022 to FY 2025), Collaboration receivable shows an upward trend with a 5.7% CAGR.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ4 2022

Last reportedQ1 2026May 1, 2026

Metric ID: other_collaboration_receivable_current

Historical Data

13 periods

	Q4 '22	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$11.00M	$41.00M	$44.00M	$61.00M	$59.00M	$73.00M	$99.00M	$58.00M	$26.00M	$20.00M	$9.00M	$13.00M	$1.00M
QoQ Change	—	+272.7%	+7.3%	+38.6%	-3.3%	+23.7%	+35.6%	-41.4%	-55.2%	-23.1%	-55.0%	+44.4%	-92.3%
YoY Change	—	—	—	+454.5%	—	+78.0%	+125.0%	-4.9%	-55.9%	-72.6%	-90.9%	-77.6%	-96.2%

Range$1.00M – $99.00M

CAGR-55.0%

Avg YoY Growth+28.8%

Median YoY Growth-55.9%

Frequently Asked Questions

What is Moderna's collaboration receivable?: Moderna (MRNA) reported collaboration receivable of $1.00M in Q1 2026.
How has Moderna's collaboration receivable changed year-over-year?: Moderna's collaboration receivable decreased by 96.2% year-over-year, from $26.00M to $1.00M.
What is the long-term trend for Moderna's collaboration receivable?: Over 3 years (2022 to 2025), Moderna's collaboration receivable has grown at a 5.7% compound annual growth rate (CAGR), from $11.00M to $13.00M.